AI Science Tracker
EN

Identification of patients with dilated phase of hypertrophic cardiomyopathy using a convolutional neural network applied to multiple, dual, and single lead electrocardiograms

Affiliation not stated in the reviewed material · 25 Apr 2023 · medicine

Discovery

Identification of patients with dilated phase of hypertrophic cardiomyopathy using a convolutional neural network applied to multiple, dual, and single lead electrocardiograms

Source check: Source checked. Not independent scientific confirmation.

Finding: A CNN applied to ECGs identified dilated-phase hypertrophic cardiomyopathy in a retrospective single-center cohort; in the held-out test data the eight-lead AUC was 0.929 and V5 single-lead AUC 0.953. This is a specific diagnostic-validation result, not evidence of clinical deployment. PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result.

Technology: PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result.
Test and result
PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result.
Limitation / still unknown
PMC10160501 Methods/Results: Shinken cohort, 17,378 analyzed subjects, 54 dHCM cases, CNN, five-run internal test evaluation and lead comparisons. Small positive cohort and no external validation limit scope. Catalog DCM ECG paper is a different disease/model/cohort, not same result. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10160501/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.